Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q1 2017 · 10-Q
Revenue$210.06K$210.06K−19.1% vs Q1 2016 Net Income-$61.92K-$61.92KN/M vs Q1 2016 EPS Diluted-$0.01-$0.01— vs Q1 2016 Gross Profit$104,539−21.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flow-$38,234N/M Free Cash Flowderived-$54,613N/M Margins · derivedGross margin49.8%−1.6 pt vs Q1 2016
Operating margin-29.2%−33.7 pt vs Q1 2016
Net margin-29.5%−34.1 pt vs Q1 2016
ended Mar 31, 2017 · filed May 18, 2017 · 48 d after period end